186 related articles for article (PubMed ID: 34261446)
1. Evaluating the association of social needs assessment data with cardiometabolic health status in a federally qualified community health center patient population.
Drake C; Lian T; Trogdon JG; Edelman D; Eisenson H; Weinberger M; Reiter K; Shea CM
BMC Cardiovasc Disord; 2021 Jul; 21(1):342. PubMed ID: 34261446
[TBL] [Abstract][Full Text] [Related]
2. Implementation of social needs screening in primary care: a qualitative study using the health equity implementation framework.
Drake C; Batchelder H; Lian T; Cannady M; Weinberger M; Eisenson H; Esmaili E; Lewinski A; Zullig LL; Haley A; Edelman D; Shea CM
BMC Health Serv Res; 2021 Sep; 21(1):975. PubMed ID: 34530826
[TBL] [Abstract][Full Text] [Related]
3. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
[TBL] [Abstract][Full Text] [Related]
4. Association of Patient-Reported Social Needs with Emergency Department Visits and Hospitalizations Among Federally Qualified Health Center Patients.
Drake C; Alfaro JM; Rader A; Maciejewski ML; Lee MS; Xu H; Wilson LE; Berkowitz SA; Eisenson H
J Gen Intern Med; 2024 May; ():. PubMed ID: 38717665
[TBL] [Abstract][Full Text] [Related]
5. An intensive follow-up in subjects with cardiometabolic high-risk.
Pérez HA; Adeoye AO; Aballay L; Armando LA; García NH
Nutr Metab Cardiovasc Dis; 2021 Sep; 31(10):2860-2869. PubMed ID: 34353703
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and clinical correlates of adverse childhood experiences in a cross-sectional study of primary care patients with cardiometabolic disease or risk factors.
Maunder RG; Tannenbaum DW; Permaul JA; Nutik M; Haber C; Mitri M; Costantini D; Hunter JJ
BMC Cardiovasc Disord; 2019 Dec; 19(1):304. PubMed ID: 31881981
[TBL] [Abstract][Full Text] [Related]
8. Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England.
Abner S; Gillies CL; Shabnam S; Zaccardi F; Seidu S; Davies MJ; Adeyemi T; Khunti K; Webb DR
Cardiovasc Diabetol; 2022 Jan; 21(1):8. PubMed ID: 35012531
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Optimal Metabolic Health in U.S. Adolescents, NHANES 2007-2016.
Choi YS; Beltran TA; Klaric JS
Metab Syndr Relat Disord; 2021 Feb; 19(1):56-63. PubMed ID: 33170075
[No Abstract] [Full Text] [Related]
10. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.
Drager LF; Togeiro SM; Polotsky VY; Lorenzi-Filho G
J Am Coll Cardiol; 2013 Aug; 62(7):569-76. PubMed ID: 23770180
[TBL] [Abstract][Full Text] [Related]
11. Association of Unmet Social Needs with Chronic Illness: A Cross-Sectional Study.
Byhoff E; Guardado R; Xiao N; Nokes K; Garg A; Tripodis Y
Popul Health Manag; 2022 Apr; 25(2):157-163. PubMed ID: 35171031
[TBL] [Abstract][Full Text] [Related]
12. Social Risk of Pregnant Women at a Community Health Center: An Application of the PRAPARE Assessment Tool.
Luzius A; Merriweather M; Busch S; James O; Dobbs PD
J Immigr Minor Health; 2023 Dec; 25(6):1254-1260. PubMed ID: 37284968
[TBL] [Abstract][Full Text] [Related]
13. LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX, AND CHINESE VISCERAL ADIPOSITY INDEX AS MARKERS OF CARDIOMETABOLIC RISK IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: A CROSS-SECTIONAL STUDY.
Xie X; Li Q; Zhang L; Ren W
Endocr Pract; 2018 Jan; 24(1):33-39. PubMed ID: 29144802
[TBL] [Abstract][Full Text] [Related]
14. Using structured and unstructured data to identify patients' need for services that address the social determinants of health.
Vest JR; Grannis SJ; Haut DP; Halverson PK; Menachemi N
Int J Med Inform; 2017 Nov; 107():101-106. PubMed ID: 29029685
[TBL] [Abstract][Full Text] [Related]
15. Development of PRAPARE Social Determinants of Health Clusters and Correlation with Diabetes and Hypertension Outcomes.
Wan W; Li V; Chin MH; Faldmo DN; Hoefling E; Proser M; Weir RC
J Am Board Fam Med; 2022; 35(4):668-679. PubMed ID: 35896473
[TBL] [Abstract][Full Text] [Related]
16. Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association.
Suglia SF; Koenen KC; Boynton-Jarrett R; Chan PS; Clark CJ; Danese A; Faith MS; Goldstein BI; Hayman LL; Isasi CR; Pratt CA; Slopen N; Sumner JA; Turer A; Turer CB; Zachariah JP;
Circulation; 2018 Jan; 137(5):e15-e28. PubMed ID: 29254928
[TBL] [Abstract][Full Text] [Related]
17. Relationships between enabling services use and access to care among adults with cardiometabolic risk factors: findings from the 2014 National Health Center Patient Survey.
Martinez GS; White K; Yue D; Franzini L; Fryer CS; Sinaii N; Roby DH
BMC Health Serv Res; 2022 Mar; 22(1):334. PubMed ID: 35287668
[TBL] [Abstract][Full Text] [Related]
18. Association Between Social Vulnerability Index and Cardiovascular Disease: A Behavioral Risk Factor Surveillance System Study.
Jain V; Al Rifai M; Khan SU; Kalra A; Rodriguez F; Samad Z; Pokharel Y; Misra A; Sperling LS; Rana JS; Ullah W; Medhekar A; Virani SS
J Am Heart Assoc; 2022 Aug; 11(15):e024414. PubMed ID: 35904206
[TBL] [Abstract][Full Text] [Related]
19. Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf.
Al-Zakwani I; Al-Mahmeed W; Arafah M; Al-Hinai AT; Shehab A; Al-Tamimi O; Al-Awadhi M; Al-Herz S; Al-Anazi F; Al-Nemer K; Metwally O; Al-Khadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al-Jassim O; Al-Hallaq O; Baslaib FO; Amin H; Santos RD; Al-Waili K; Al-Hashmi K; Al-Rasadi K
Curr Vasc Pharmacol; 2016; 14(4):374-81. PubMed ID: 26496982
[TBL] [Abstract][Full Text] [Related]
20. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
